Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic

IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic prompted policy changes to allow increased telehealth delivery of buprenorphine, a potentially lifesaving medication for opioid use disorder (OUD). It is unclear how characteristics of patients who access different treatment modalities (in...

Descripción completa

Detalles Bibliográficos
Autores principales: Frost, Madeline C., Zhang, Lan, Kim, H. Myra, Lin, Lewei (Allison)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557869/
https://www.ncbi.nlm.nih.gov/pubmed/36223118
http://dx.doi.org/10.1001/jamanetworkopen.2022.36298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557869/
https://www.ncbi.nlm.nih.gov/pubmed/36223118
http://dx.doi.org/10.1001/jamanetworkopen.2022.36298

Ejemplares similares